Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.
about
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactamsAnti-pseudomonal beta-lactam monotherapy for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactamsExtended-spectrum beta-lactamases: a clinical updateEnterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literatureImproving antimicrobial prescribing in Irish primary care through electronic data collection and surveillance: a feasibility study.Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacaeExtended-spectrum β-lactamases in Gram Negative Bacteria.Beyond Susceptible and Resistant, Part I: Treatment of Infections Due to Gram-Negative Organisms With Inducible β-LactamasesTemporal trends in Enterobacter species bloodstream infection: a population-based study from 1998-2007Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region.Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter speciesFluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens.Nursing home residents and Enterobacteriaceae resistant to third-generation cephalosporins.Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study: healthcare-associated Gram-negative BSI.Current epidemiology and growing resistance of gram-negative pathogens.The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance.Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.AmpC beta-lactamases.The use of carbapenems in the treatment of serious infections.Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study.Impact of treatment strategies on cephalosporin and tetracycline resistance gene quantities in the bovine fecal metagenome.Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back?Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.Treatment of multidrug-resistant Gram-negative infections in children.Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.Complex Regulation Pathways of AmpC-Mediated β-Lactam Resistance in Enterobacter cloacae Complex.Prevalence of Carbapenemases and Metallo-β-lactamases in Clinical Isolates of Enterobacter Cloacae.Serratia bacteremia in a large university hospital: trends in antibiotic resistance during 10 years and implications for antibiotic use.Pediatric antimicrobial susceptibility trends across the United States.Resistance in Enterobacteriaceae: results of a multicenter surveillance study, 1995-2000.Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species.Gram-negative bacterial resistance to cephalosporins in community-acquired infections in Turkey.Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units.Cefepime resistance and associated risk factors among Escherichia coli strains isolated from clinical specimens.Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.Pantoea agglomerans in immunodeficient patients with different respiratory symptoms
P2860
Q24236653-623D98B9-875F-4D56-8B03-4C9A72876D11Q24243072-6D3F5325-8615-424B-ADA9-70C7E06E1280Q24534999-029076F9-B9E0-434F-99BF-14FA830FC7F2Q28189190-C7CA340C-C370-4BEF-8239-BC9C75E4BB61Q30978227-64841E6D-C1E3-4D15-89F5-03A480C2D1A5Q33598276-F70F696D-9256-47D0-B7DF-4953E3CBA857Q33857230-DF968717-5320-433A-A120-569C09C9FA38Q34073514-4886B515-61C6-41BA-BA15-091D871B5DDFQ34159849-DEC064CB-E058-4342-90A2-435ACA07D19CQ34266074-79A5EF23-169B-46A9-9DCB-EA7B16E71D6DQ34274088-68B430C2-64E7-492F-A9AA-8BF770C18121Q34560162-4A4F2147-0F83-4616-95CB-BC0BF3305870Q34987739-79B8A3B1-FD42-46DD-B9FF-E7D2EEB66CF0Q35014507-C15538CB-1FD7-403A-ABD1-4624DD5235E5Q35879246-0AACC9AF-55A2-4AB8-9438-AF2C246555CEQ35880482-BAF22E6B-BF53-40A0-B43A-B3DD28CC5CB4Q36014795-7C4A95CC-75B4-437C-A0C3-0C795B7FE52BQ36025192-315D3796-29F3-46BD-ACB1-F13171989E6EQ36112353-C31B7186-A36B-4D3D-9B57-79153BBFA522Q36538655-C3D19E56-ED97-4CCF-8CE5-6852002E0863Q37366249-6C5F2596-8B20-476E-9981-FEF5CA4E88BDQ37555757-61B44D1F-47DA-43D1-A999-4C880263517FQ37597301-B8A20BCB-4391-496B-BD69-6E2FD6DCDC4AQ37738498-643B3A5E-2F8C-438C-A1D8-0C62806C87AEQ37949391-A4A7F542-07B8-4195-94ED-4B353D46F839Q38068483-8B9B4728-2531-44BB-BFB0-E285C9D31ABAQ38069872-10AF546E-B086-4570-BF83-5392751D676CQ38185648-62C940CA-9CF8-4CC5-A1BF-1B8918B06D85Q39048083-21B15284-2959-4B04-8299-BA540E938BC9Q40965343-F80BC52D-7F9F-4229-98C9-155E9DD017B1Q41817117-07C41213-689B-4693-AC8A-DA01FF86E35EQ44271612-51875CB9-7E35-4099-9ACC-605A88D82B22Q44387036-4D1293CF-2AEA-45AA-807F-307D78BD1ABDQ44563019-D7DABBC4-1D9A-4C29-A909-7B8524E7C82CQ45252185-7E5E84C1-47F4-4BC1-AFC7-8EFCC98572CFQ46436176-C6D4BED7-9231-45ED-829A-9264BFE8C267Q49033667-2182EFE7-F9A0-43A1-A2C4-A54D4303214EQ51043534-97805F83-3610-4CEA-A5E6-6B3516E669D7Q51924519-95120F7D-B73D-4A2D-9FB9-A6037070137DQ58914600-A0BF9887-5F75-43F4-BDC1-3443F7DCB12F
P2860
Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Risk factors for emergence of ...... porins among Enterobacter spp.
@ast
Risk factors for emergence of ...... porins among Enterobacter spp.
@en
type
label
Risk factors for emergence of ...... porins among Enterobacter spp.
@ast
Risk factors for emergence of ...... porins among Enterobacter spp.
@en
prefLabel
Risk factors for emergence of ...... porins among Enterobacter spp.
@ast
Risk factors for emergence of ...... porins among Enterobacter spp.
@en
P2093
P2860
P1476
Risk factors for emergence of ...... porins among Enterobacter spp.
@en
P2093
P2860
P304
P356
10.1128/AAC.45.9.2628-2630.2001
P407
P577
2001-09-01T00:00:00Z